Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Malek R, Chong AY, Lupsa BC, Lungu AO, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P.

J Clin Endocrinol Metab. 2010 Aug;95(8):3641-7. doi: 10.1210/jc.2010-0167. Epub 2010 May 19.

PMID:
20484479
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.

Yamamoto T, Sato T, Mori T, Yamakita T, Hasegawa T, Miyamoto M, Hosoi M, Ishii T, Yoshioka K, Tanaka S, Fujii S.

Diabetes Res Clin Pract. 2000 Jul;49(1):65-9.

PMID:
10808065
[PubMed - indexed for MEDLINE]
3.

Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.

Vesely DL, Coleman MJ, Kohler PO, Jordan RM, Stanley S.

Am J Med. 1985 Oct;79(4):504-8.

PMID:
3931471
[PubMed - indexed for MEDLINE]
4.

Insulin receptor antibodies and insulin resistance.

Magsino CH Jr, Spencer J.

South Med J. 1999 Jul;92(7):717-9.

PMID:
10414483
[PubMed - indexed for MEDLINE]
5.

Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.

Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P.

Medicine (Baltimore). 2002 Mar;81(2):87-100. No abstract available.

PMID:
11889410
[PubMed - indexed for MEDLINE]
6.

Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.

Fareau GG, Maldonado M, Oral E, Balasubramanyam A.

Metabolism. 2007 May;56(5):670-5.

PMID:
17445543
[PubMed - indexed for MEDLINE]
7.

Rituximab therapy for the type B syndrome of severe insulin resistance.

Coll AP, Thomas S, Mufti GJ.

N Engl J Med. 2004 Jan 15;350(3):310-1. No abstract available.

PMID:
14724317
[PubMed - indexed for MEDLINE]
Free Article
8.

Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.

Baird JS, Johnson JL, Elliott-Mills D, Opas LM.

Lupus. 1997;6(3):275-8.

PMID:
9104736
[PubMed - indexed for MEDLINE]
9.

Type B insulin resistance complicated with systemic lupus erythematosus.

Kawashiri SY, Kawakami A, Fujikawa K, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ida H, Eguchi K.

Intern Med. 2010;49(5):487-90. Epub 2010 Mar 1.

PMID:
20190490
[PubMed - indexed for MEDLINE]
Free Article
10.

Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.

Sims RE, Rushford FE, Huston DP, Cunningham GR.

South Med J. 1987 Jul;80(7):903-6.

PMID:
3603112
[PubMed - indexed for MEDLINE]
11.

Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.

el-Reshaid K, al-Mofti S, Stepic NR.

Diabetes Res Clin Pract. 1994 Oct;25(3):207-10.

PMID:
7851276
[PubMed - indexed for MEDLINE]
12.

Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.

Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW.

Diabetes Care. 1998 Aug;21(8):1217-20.

PMID:
9702422
[PubMed - indexed for MEDLINE]
13.

Insulin receptor autoimmunity and insulin resistance.

Zhou P, Ten S, Sinha S, Ramchandani N, Vogiatzi M, Maclaren N.

J Pediatr Endocrinol Metab. 2008 Apr;21(4):369-75.

PMID:
18556968
[PubMed - indexed for MEDLINE]
14.

Type B insulin resistance syndrome associated with systemic lupus erythematosus.

Bao S, Root C, Jagasia S.

Endocr Pract. 2007 Jan-Feb;13(1):51-5.

PMID:
17360301
[PubMed - indexed for MEDLINE]
15.

Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.

Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW.

Diabetes. 1985 Feb;34(2):101-7.

PMID:
3881301
[PubMed - indexed for MEDLINE]
16.

Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies.

Kellett HA, Collier A, Taylor R, Sawers JS, Benton C, Doig A, Baird D, Clarke BF.

Metabolism. 1988 Jul;37(7):656-9.

PMID:
3386533
[PubMed - indexed for MEDLINE]
17.

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.

Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P.

Medicine (Baltimore). 2004 Jul;83(4):209-22. Review.

PMID:
15232309
[PubMed - indexed for MEDLINE]
18.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
[PubMed - indexed for MEDLINE]
19.

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Nachman PH, Hogan SL, Jennette JC, Falk RJ.

J Am Soc Nephrol. 1996 Jan;7(1):33-9.

PMID:
8808107
[PubMed - indexed for MEDLINE]
Free Article
20.

Type B insulin resistance in a systemic lupus erythematosus patient.

Ostwal V, Oak J.

Int J Rheum Dis. 2009 Jul;12(2):174-6. doi: 10.1111/j.1756-185X.2009.01402.x.

PMID:
20374339
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk